A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis (clinicaltrials.gov) - Sep 24, 2026 - P2 | N=63 | Terminated | Sponsor: Eli Lilly and Company | Active, not recruiting ➔ Terminated; The interim analysis data failed to demonstrate the intended treatment effect.
Trial termination • CNS Disorders • Multiple Sclerosis
|